Author

S. Zeghbib

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Organism:mouse· 2 Approach:statistical model· 2 Assay:whole-genome sequencing· 2 Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

F. Jakab· 4 shared G. Kemenesi· 4 shared G. E. Toth· 3 shared Z. Lanszki· 3 shared A. J. Hume· 2 shared A. Nagy· 2 shared B. Zana· 2 shared C. I. Pereszlenyi· 2 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersMicrobiology

F. Jakab

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Isolation and genome characterization of Lloviu virus from Italian Schreibers bent-winged bats

G. E. Toth, A. J. Hume, E. L. Suder, S. Zeghbib, A. Abraham, Z. Lanszki, Z. Varga, Z. Tauber, F. Foldes, B. Zana, D. Scaravelli, M. T. Scicluna, A. Pereswiet-Soltan, T. Gorfol, C. Terregino, , G. Kemenesi

The paper isolates and characterizes Lloviu virus from Italian bats, establishing an infectious isolate and conducting evolutionary analysis.

bioRxiv · Dec 5, 2022 · PreprintMicrobiology

Reservoir host studies of Lloviu virus: first isolation, sequencing and serology in Schreiber's bats in Europe

G. Kemenesi, G. E. Toth, M. Mayora-Neto, S. Scott, N. Temperton, E. Wright, E. Muhlberger, A. J. Hume, B. Zana, S. A. Boldogh, T. Gorfol, P. Estok, Z. Lanszki, B. A. Somogyi, A. Nagy, , F. Jakab

This study isolates and characterizes Lloviu virus from Schreiber's bats in Europe, showing its ability to infect human and monkey cells and suggesting potential spillover risks.

bioRxiv · Aug 10, 2021Microbiology

The Anti-histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits SARS-CoV-2 Infection in Reconstituted Human Nasal Tissue In Vitro

R. Konrat, H. Papp, V. Szijarto, T. Gesell, G. Nagy, M. Madai, S. Zeghbib, A. Kuczmog, Z. Lanszki, Z. Helyes, G. Kemenesi, F. Jakab, E. Nagy

This paper identifies azelastine, an anti-histamine drug, as a potential inhibitor of SARS-CoV-2 infection through computational repurposing and in vitro testing in human nasal tissue.

bioRxiv · Sep 15, 2020 · PreprintMicrobiology

Multiple SARS-CoV-2 introductions shaped the early outbreak in Central Eastern Europe: comparing Hungarian data to a worldwide sequence data-matrix

G. Kemenesi, S. Zeghbib, B. Somogyi, G. E. Toth, K. Banyai, N. Solymosi, P. M. Szabo, I. Szabo, A. Balint, P. Urban, R. Herczeg, A. Gyenesei, A. Nagy, C. I. Pereszlenyi, G. Babinszky, , F. Jakab

The paper analyzes SARS-CoV-2 genomic data from Hungary to identify multiple introduction events into Central-Eastern Europe using haplotype networks and phylogenetic analysis.

bioRxiv · May 6, 2020Microbiology